Association of high sensitivity C-reactive protein concentrations and metabolic syndrome among Thai adults

1. Paniagua L, Lohsoonthorn V, Lertmaharit S, Jiamjarasrangsi W, Williams MA. Comparison of waist circumference, body mass index, percent body fat and other measure of adiposity in identifying cardiovascular disease risks among Thai adults. Obesity Res Clin Pract. 2008; 2:215-23.10.1016/j.orcp.2008.05.003362742323599834Open DOISearch in Google Scholar

2. World Health Organization. Cardiovascular Diseases. Geneva: World Health Organization; [cited 2009].Search in Google Scholar

3. Bureau of Health Policy and Plan, Office of Permanent Secretary, Ministry of Public Health. Thailand Health Profile 1997-1998. Bangkok: Printing Press, Express Transportation Organization, 2000.Search in Google Scholar

4. Hassinen M, Lakka TA, Komulainen P, Gylling H, Nissinen A, Rauramaa R. C-reactive protein and metabolic syndrome in elderly women: a 12-year follow-up study. Diabetes Care. 2006; 29:931-2.10.2337/diacare.29.04.06.dc05-250816567842Open DOISearch in Google Scholar

5. Lee JG, Lee S, Kim YJ, Jin HK, Cho BM, Jeong DW, et al. Multiple biomarkers and their relative contributions to identifying metabolic syndrome. ClinChim Acta. 2009; 408:50-5.10.1016/j.cca.2009.07.00619622349Search in Google Scholar

6. Okosun IS. Metabolic syndrome and C-reactive protein in American adults: the impact of abdominal obesity. Metab Syndr Relat Disord. 2008; 6:289-97.10.1089/met.2008.004019067532Search in Google Scholar

7. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002; 287:356-9.10.1001/jama.287.3.35611790215Search in Google Scholar

8. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003; 107:391-7.10.1161/01.CIR.0000055014.62083.05Search in Google Scholar

9. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006; 23:469-80.10.1111/j.1464-5491.2006.01858.x16681555Search in Google Scholar

10. Nash DT. Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins. J Natl Med Assoc. 2005; 97:1600-7.Search in Google Scholar

11. Osman R, L’Allier PL, Elgharib N, Tardif JC. Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease. Vasc Health Risk Manag. 2006; 2:221-37.10.2147/vhrm.2006.2.3.221199397917326329Search in Google Scholar

12. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998; 98:731-3.10.1161/01.CIR.98.8.731Open DOISearch in Google Scholar

13. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990; 12: 1179-86.10.1002/hep.18401205171699862Search in Google Scholar

14. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998; 22:1145-58.10.1038/sj.ijo.0800770Search in Google Scholar

15. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. Creactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999; 19:972-8.10.1161/01.ATV.19.4.972Search in Google Scholar

16. Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, et al. The use of highsensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med. 2008; 5: 621-35.10.1038/ncpcardio1322Open DOISearch in Google Scholar

17. Wang J, Thornton JC, Bari S, Williamson B, Gallagher D, Heymsfield SB, et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr. 2003; 77:379-84.10.1093/ajcn/77.2.379Search in Google Scholar

18. NCEP. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-97.10.1001/jama.285.19.2486Search in Google Scholar

19. Shiwaku K, Anuurad E, Enkhmaa B, Kitajima K, Yamane Y. Appropriate BMI for Asian populations. Lancet. 2004; 363:1077.10.1016/S0140-6736(04)15856-XSearch in Google Scholar

20. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.Search in Google Scholar

21. Aronson D, Sella R, Sheikh-Ahmad M, Kerner A, Avizohar O, Rispler S, et al. The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome. J Am Coll Cardiol. 2004; 44:2003-7.10.1016/j.jacc.2004.08.03015542283Search in Google Scholar

22. Laaksonen DE, Niskanen L, Nyyssonen K, Punnonen K, Tuomainen TP, Valkonen VP, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004; 47: 1403-10.10.1007/s00125-004-1472-x15309290Search in Google Scholar

23. Saltevo J, Vanhala M, Kautiainen H, Kumpusalo E, Laakso M. Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome. Mediators Inflamm. 2007; 2007:93573.10.1155/2007/93573222266618288276Search in Google Scholar

24. Chapidze G, Dolidze N, Enquobahrie DA, Kapanadze S, Latsabidze N, Williams MA. Metabolic syndrome and C-reactive protein among cardiology patients. Arch Med Res. 2007; 38:783-8.10.1016/j.arcmed.2007.03.01117845899Search in Google Scholar

25. Ford ES, Ajani UA, Mokdad AH. The metabolic syndrome and concentrations of C-reactive protein among US youth. Diabetes Care. 2005; 28:878-81.10.2337/diacare.28.4.87815793189Open DOISearch in Google Scholar

26. Lee WY, Park JS, Noh SY, Rhee EJ, Sung KC, Kim BS, et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int J Cardiol. 2004; 97:101-6.10.1016/j.ijcard.2003.08.01615336815Search in Google Scholar

27. Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB, Sr., Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004; 110:380-5.10.1161/01.CIR.0000136581.59584.0E15262834Search in Google Scholar

28. Yan E, Chen S, Hong K, Kim WS, Bajpai A, Treyzon L, et al. Insulin, hs-CRP, leptin, and adiponectin. An analysis of their relationship to the metabolic syndrome in an obese population with an elevated waist circumference. Metab Syndr Relat Disord. 2008; 6: 64-73.10.1089/met.2007.002718370838Search in Google Scholar

29. Paoletti R, Bolego C, Poli A, Cignarella A. Metabolic syndrome, inflammation and atherosclerosis. Vasc Health Risk Manag. 2006; 2:145-52.10.2147/vhrm.2006.2.2.145199399217319458Search in Google Scholar